Natalie McNamee

Natalie McNamee

Inversor de Capital Privado en Tarnagulla Ventures Pty Ltd. .

Consumer Services
Health Technology
Finance

Perfil

Natalie has been a Director of Tarnagulla Ventures Pty Ltd since 2015.
She had led the investment diligence into most of the portfolio companies since then, including Lubris BioPharma, a company which has since successfully licensed their lead indication to Novartis.
Prior to returning to Australia, Natalie worked for Tocagen Inc, a gene therapy company, based in San Diego, in their business development team whilst finishing her Masters.
She then worked as a bioengineer at the then-newly formed Quanticel Pharmaceuticals, a cancer stem cell focused drug developer.
Quanticel was acquired by Celgene for $485M in 2015.
Natalie received her Masters in Bioengineering at UC San Diego and a dual Bachelor of Finance and Mechanical Engineering from Melbourne University.

Cargos activos de Natalie McNamee

EmpresasCargoInicio
Inversor de Capital Privado 01/01/2015
Todos los cargos activos de Natalie McNamee

Antiguos cargos conocidos de Natalie McNamee.

Formación de Natalie McNamee.

University of California San Diego Graduate Degree
University of Melbourne Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Natalie McNamee.

Relaciones

1

Relaciones de 1er grado

4

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas2

Health Technology

Finance

Ver las conexiones de la empresa